465 results on '"Rummel, Andreas"'
Search Results
102. A lipid-binding loop of botulinum neurotoxin serotypes B, DC and G is an essential feature to confer their exquisite potency
103. An Interview with Cesare Montecucco
104. Botulinum neurotoxin C mutants reveal different effects of syntaxin or SNAP-25 proteolysis on neuromuscular transmission
105. Physical fault isolation of complex BEOL defects in advanced microprocessors using EBAC technique in nano-prober
106. In Situ Nanoprobing Tools for Fault Localization and Defect Characterization
107. Historical Perspectives and Guidelines for Botulinum Neurotoxin Subtype Nomenclature
108. A NanoWorkshop Toolkit for in situ Nanoassembly and Nanocharacterization
109. Combining Current Imaging and Electrical Probing for fast and reliable in situ Electrical Fault Isolation
110. In vitro and in vivo evaluation of syntaxin-specific BoNT/C
111. Biological toxins of potential bioterrorism risk: Current status of detection and identification technology
112. A functional assay devoid of antibodies for serotyping and detection of botulinum neurotoxins
113. Detection and differentiation of botulinum neurotoxin serotypes C, D, and their mosaic variants by highly specific immunoassays and mass spectrometry
114. Binding of botulinum neurotoxin (BoNT) to glycosylated SV2
115. Isolation and functional characterization of the novel Clostridium botulinum neurotoxin A8 subtype
116. Combining Current Imaging, EBIC/EBAC, and Electrical Probing for Fast and Reliable In-Situ Electrical Fault Isolation
117. Only the complex N559-glycan in the synaptic vesicle glycoprotein 2C mediates high affinity binding to botulinum neurotoxin serotype A1
118. Combining current imaging, EBIC/EBAC, and electrical probing for fast and reliable in situ electrical fault isolation
119. Botulinum Neurotoxin Serotype A Recognizes Its Protein Receptor SV2 by a Different Mechanism than Botulinum Neurotoxin B Synaptotagmin
120. Detection, differentiation, and identification of botulinum neurotoxin serotypes C, CD, D, and DC by highly specific immunoassays and mass spectrometry
121. Preface Biological Toxins—Ancient Molecules Posing a Current Threat
122. Structural and biochemical characterization of the protease domain of the mosaic botulinum neurotoxin type HA.
123. Human synaptotagmin-II is not a high affinity receptor for botulinum neurotoxin B and G: Increased therapeutic dosage and immunogenicity
124. Qualitative and Quantitative Detection of Botulinum Neurotoxins from Complex Matrices: Results of the First International Proficiency Test
125. Generation and Characterization of Six Recombinant Botulinum Neurotoxins as Reference Material to Serve in an International Proficiency Test
126. Botulinum Neurotoxins: Qualitative and Quantitative Analysis Using the Mouse Phrenic Nerve Hemidiaphragm Assay (MPN)
127. Resistive Contrast Imaging—The Tool, Technique, and Applications on Leading-Edge Semiconductor Technology Devices
128. Electrical Probing and Current Imaging for Failure Analysis in the SEM/FIB
129. Isolation and Functional Characterization of the Novel Clostridium botulinum Neurotoxin A8 Subtype
130. 174. BoNT complexes and their journey toward the nervous system
131. 124. Isolation and functional characterization of the novel Clostridium botulinum A8 neurotoxin subtype
132. 209. Foodborne botulism in 2 adults not treated by antiserum
133. 205. Characterizing the interaction of botulinum neurotoxin type A with rat and human SV2C
134. 128. Molecular basis for disruption of E-cadherin adhesion by botulinum neurotoxin type A complex
135. 132. Insights into the glycosylation-status dependent interaction of SV2C with botulinum neurotoxin type A
136. 208. About the disappearance and peculiar reappearance of BoNT/A
137. Draft Genome Sequence of Bivalent Clostridium botulinum Strain IBCA10-7060, Encoding Botulinum Neurotoxin B and a New FA Mosaic Type
138. Characterisation of the cell binding domain of clostridial neurotoxins
139. Structure of a Bimodular Botulinum Neurotoxin Complex Provides Insights into Its Oral Toxicity
140. Human mast cell line-1 (HMC-1) cells exhibit a membrane capacitance increase when dialysed with high free-Ca2+ and GTPγS containing intracellular solution
141. Neutralisation of specific surface carboxylates speeds up translocation of botulinum neurotoxin type B enzymatic domain
142. Structure of a Bimodular Botulinum Neurotoxin Complex Provides Insights into Its Oral Toxicity
143. Repairing bonding wire connections using a microsoldering unit inside an SEM
144. Identification of the SV2 protein receptor-binding site of botulinum neurotoxin type E
145. Substrates and Controls for the Quantitative Detection of Active Botulinum Neurotoxin in Protease-Containing Samples
146. Botulinum Neurotoxin G Binds Synaptotagmin-II in a Mode Similar to That of Serotype B: Tyrosine 1186 and Lysine 1191 Cause Its Lower Affinity
147. A new approach for making electrically conductive interconnections between small contacts in failure analysis
148. Activation of metabotropic GABA receptors increases the energy barrier for vesicle fusion
149. Botulinum neurotoxin serotype D attacks neurons via two carbohydrate-binding sites in a ganglioside-dependent manner
150. Achieving Fast and Reliable TEM-Sample Lift-out and Transfer Using Novel Materials and Novel in-situ Tools
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.